Quarterly Result6 Aug 2026, 07:21 pm
Zim Labs Presents Q1 FY27 Earnings Presentation
AI Summary
Zim Laboratories Ltd has released its Earnings Presentation for the first quarter of Fiscal Year 2027 (Q1 FY27). The presentation details financial performance, including Total Operating Income of ₹942 Mn, a decrease from ₹718 Mn in Q1 FY26. EBITDA stood at ₹34 Mn, down from ₹57 Mn in the prior year's quarter, resulting in a lower EBITDA margin of 3.7% compared to 7.9% in Q1 FY26. The company also reported a Total R&D Spend of ₹82 Mn, which included ₹34 Mn for BE studies and regulatory filings. The presentation covers business mix, R&D and innovation pipeline progress, and shareholding structure.
Key Highlights
- Q1 FY27 Total Operating Income reported at ₹942 Mn.
- EBITDA decreased to ₹34 Mn from ₹57 Mn year-on-year.
- EBITDA margin declined to 3.7% from 7.9% in Q1 FY26.
- Total R&D Spend for the quarter was ₹82 Mn.
Price Impact
More from ZIMLAB